NorthWest Biotherapeutics Inc (NWBO)

[Moses3]

We will get some sort of public news release but don’t expect the actual numbers. They will say it either met endpoints or did not. My guess is it will not hit on OS because they included such a high degree of cross over which is hands down the dumbest thing I ever heard for an unapproved therapy to do.... like literally stupid. They will have something, I believe, in the release that says though they failed to meet the endpoint the subgroup analysis shows improved patient populations. Now, just because they ran a shitty study, does not mean the company will go bankrupt. If the data is good, after publication, they will have big pharmaceutical make a buy out offer, and all of our dumbass selves who decided to stay long May at least walk away whole...but I am speculating. Now this is all my opinion, I don’t really know anything. But they won’t risk publication by sharing the hard numbers.